Journal article
Vasopressin in Pediatric Vasodilatory Shock
Abstract
RATIONALE: Vasopressin has been proposed as a potent vasoactive agent in the treatment of vasodilatory shock in adults and children. The objective of this trial was to evaluate the efficacy and safety of vasopressin as an adjunctive agent in pediatric vasodilatory shock.
METHODS: In this multicenter, double-blind trial, children with vasodilatory shock were randomized to receive low-dose vasopressin (0.0005-0.002 U/kg/min) or placebo in …
Authors
Choong K; Bohn D; Fraser DD; Gaboury I; Hutchison JS; Joffe AR; Litalien C; Menon K; McNamara P; Ward RE
Journal
American Journal of Respiratory and Critical Care Medicine, Vol. 180, No. 7, pp. 632–639
Publisher
American Thoracic Society
Publication Date
October 1, 2009
DOI
10.1164/rccm.200902-0221oc
ISSN
1073-449X